Merck Serono
Our active ingredient is Innovation
At Merck Serono, we are actively committed to bringing therapeutic innovations to patients. We specialise in the treatment
of cancer, neurodegenerative diseases, infertility, endocrine and metabolic disorders, cardiovascular diseases and other conditions
with unmet medical needs.
Around the world, some 17,000 employees work to discover, develop, manufacture and commercialise Merck Serono’s prescription
therapies, available in over 150 countries.
We are internationally recognised as a biotechnology leader, with innovative and successful products along with a well-stocked
and promising development pipeline. Specialised know-how in research and production means that we are able to ensure absolutely
high-quality manufacturing, a key success factor especially in the biopharmaceutical industry.
In 2009, sales of Merck Serono products generated total revenues of € 5.3 billion. We devote 22% of these earnings to the
pursuit of innovative new therapies through our own research and development, strategic alliances and agreements.
